William Collier
Director/Board Member at Genevant Sciences Corp.
Net worth: - $ as of 30/04/2024
William Collier active positions
| Companies | Position | Start | End |
|---|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Board Member | - | - |
Career history of William Collier
Former positions of William Collier
| Companies | Position | Start | End |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 24/06/2019 | 31/12/2023 |
| Chief Executive Officer | 24/06/2019 | 31/12/2023 | |
| Investor Relations Contact | 24/06/2019 | 21/09/2021 | |
| Public Communications Contact | 24/06/2019 | - | |
| President | 24/06/2019 | 31/12/2023 | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Chief Executive Officer | - | 31/12/2023 |
| President | - | 31/12/2023 | |
International Partnership for Microbicides
 International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Director/Board Member | 01/01/2018 | 01/01/2021 |
| Aids United | Director/Board Member | 01/01/2011 | 01/01/2018 |
| Glaxowellcom | Corporate Officer/Principal | - | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | President | - | - |
Training of William Collier
| University of Manchester Institute of Science & Technology | Undergraduate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 3 |
| Canada | 2 |
Operational
| Director/Board Member | 4 |
| President | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Private companies | 6 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
International Partnership for Microbicides
International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Health Technology |
| Aids United | |
| Glaxowellcom | |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
- Stock Market
- Insiders
- William Collier
- Experience
